Long before today’s chemistry labs started perfecting multifunctional adjuvants, the basis for Polyoxyethylene (50) Stearate got laid down in the earliest days of surfactant science. During the mid-20th century, as the pharmaceutical and cosmetic industries buzzed with the search for compounds to blend oil and water, researchers noticed that modifying stearic acid with long polyoxyethylene chains gave formidable emulsifiers. As needs grew, so did the number of ethylene oxide units, ending up with the “50” we now see, signaling the average repeating units per molecule. This march from simple soap-like substances to precision-calibrated excipients mirrors the story of rising manufacturing standards and demands for cleaner, more reproducible products.
Polyoxyethylene (50) Stearate stands as a white to off-white waxy solid at room temperature. The balance between its stearate core and long hydrophilic polyoxyethylene chain lets it disperse in water with surprising ease, making it a staple in blending oil-loving and water-loving substances—something anyone in pharmaceuticals or food processing deals with daily. The pharmaceutical grades, as dictated by BP, EP, and USP standards, undergo additional testing for purity and microbial content, shaping them for use where purity can’t be compromised. Many see these materials as elegant helpers, lending creams their silky glide or keeping injectable solutions stable across real-world shipping conditions.
A single glance at Polyoxyethylene (50) Stearate reveals its waxy solid form, but dig deeper and a world of interactions comes into play. At the molecular level, the substance possesses both hydrophobic and hydrophilic regions, allowing it to sit at oil-water boundaries and reduce surface tension. In the lab, it melts between 40°C and 50°C, dissolves in water and many organic solvents, and resists hydrolysis in neutral conditions. Its chemical stability under a range of pH and moderate heat gives formulators flexibility, letting finished products travel from the factory to warm climates with minimal risk of breakdown. This reliability under stress isn’t always visible, but formulators who’ve watched batches fail due to unstable emulsions know first-hand the difference that a robust surfactant can make.
Pharmaceutical manufacturers often demand detailed facts before green-lighting any new component, and the specification sheets for Polyoxyethylene (50) Stearate offer exactly that. Look for minimum purity levels—often above 98%—and low acid and saponification values. Residual ethylene oxide, dioxane, and microbial contaminants stay strictly capped, matching EP, BP, and USP pharmacopoeial requirements. Many suppliers publish certificates of analysis with every batch and supply containers marked with lot numbers, expiration dates, and proof statements of compliance. Labels detail not just chemical identity, but also safe storage and recommended handling procedures tailored to the realities of pharmaceutical blending rooms where dust, spills, and potential cross-contamination can cause huge setbacks.
Production typically starts with pharmaceutical-grade stearic acid, sourced from either plant or animal fats and subjected to careful purification. Ethylene oxide then reacts with the stearic acid in a controlled polymerization, with tight scrutiny on temperature, pressure, and catalysts. After attaining roughly 50 ethoxy units per stearate molecule, technicians purify the resulting material to strip out catalysts, free acids, and trace by-products. The process ends with filtration, drying, and packaging under conditions that prevent moisture ingress and microbial growth. Having worked in a facility that handled similar synthesizing reactions, I’ve seen how minor lapses in process control can create off-spec batches, which underscores the importance of rigorous procedure and regular monitoring.
Although Polyoxyethylene (50) Stearate is typically used as-is, chemists sometimes modify its chain length or attach functional groups to impart extra features, such as charge or increased resistance to acidic environments. In research, mild hydrolysis and enzymatic treatments help probe its stability, and advanced analytical methods like NMR or FTIR track changes. Occasionally, researchers explore cross-linking or end-group modifications to test new delivery systems or compatibility with actives in novel formulations. Most modifications target improvement in solubility or interaction with biological membranes—a field that keeps evolving as more is learned about how formulation details affect bioavailability and patient outcomes.
Polyoxyethylene (50) Stearate answers to a handful of names. Sometimes the catalogue will call it PEG-50 Stearate, Emulgator S50, or just Steareth-50. Each name traces back to either its chemical structure or commercial branding, so cross-referencing is vital when comparing materials across regions. Some manufacturers carve out their niche by offering slight tweaks in purity, melting point, or even origin; I’ve seen specifications from North America differ just enough from European ones to require careful attention before use in international projects.
Safety always sits at the forefront in pharmaceutical environments, and handling Polyoxyethylene (50) Stearate draws from global best practices. Workers put on gloves, goggles, and dust masks to handle bulk loads. Training focuses on keeping powders from becoming airborne, proper containment, and emergency procedures in case of spills. Storage recommendations ask for dry, cool rooms, with stock rotated frequently to minimize risk of degradation. In line with E-E-A-T principles, documentation of all safety protocols becomes a regular part of equipment logs and quality management systems, not just paperwork to satisfy audits but crucial habits to protect workers and end users alike.
Applications for this surfactant run through tablet manufacturing, creams, ointments, and oral suspensions. In my time working with topical dosage forms, Polyoxyethylene (50) Stearate has been the “make-or-break” ingredient holding an emulsion together. Its role stretches to stabilizing vitamins and active ingredients, improving mouthfeel in oral solutions, and even helping microcapsule suspensions distribute evenly. Beyond pharmaceuticals, the food and cosmetics worlds draw on its power to keep ‘oil and water’ friends, offering smoother lotions and longer shelf-stable sauces. The quiet strength of this ingredient rarely gets the spotlight, but batch failures or stability issues reveal its impact in a hurry.
Investigation continues into tweaking the polymer chain structure for enhanced bio-compatibility and reduced irritancy. Scientists at several research universities experiment with attaching targeting ligands or responsive elements for “smart” drug delivery. I attended a medical formulation conference where talks revolved around blends of Polyoxyethylene (50) Stearate with natural polymers to reduce residue and improve skin feel. Current studies often look toward environmental impact, too, seeking biodegradable alternatives and lifecycle analyses to address regulatory trends. These questions aren’t just academic: any move in the regulatory environment can change sourcing and manufacturing priorities nearly overnight.
Toxicologists have zeroed in on both the concentration and cumulative exposure. Acute studies in rodents usually highlight a relatively low risk at intended pharmacopeial doses, though chronic use at very high levels can provoke mild irritation in sensitive individuals. Regulatory bodies now insist on deeper studies into potential build-up in the body and interaction with sensitive patient groups. In practice, formulators must balance the proven safety profile with individual patient variables and adjust exposure based on population and delivery route. Real-world vigilance makes all the difference, demanding regular updates to safety data sheets and ongoing supplier audits.
Polyoxyethylene (50) Stearate looks set to remain a go-to agent within the pharmaceutical and cosmetic toolkit, but the picture keeps changing. Future demand will ask it do more than just blend and stabilize; researchers push for tailored molecules that tune release rates, interact gently with skin, and degrade harmlessly after use. As regulatory agencies tighten definitions of “clean label” and “environmental safety,” manufacturers will need to trace every molecular step from raw material to finished dose. For those who enjoy problem-solving at the bench or in the boardroom, following these directions means looking at not just what the molecule does in a test tube, but how it acts in a global marketplace now focused on sustainability, transparency, and continual product improvement.
Polyoxyethylene (50) Stearate, known by many in the industry as a mouthful, usually shows up on ingredient lists as a type of pharmaceutical excipient. Not every ingredient grabs the spotlight like an active medicine; some do their best work in the background. This compound offers useful properties—blending the necessary with the practical. Derived from stearic acid and ethylene oxide, its structure lets it work as a surfactant. That means it can help oily and watery components mix where they’d rather separate and cause trouble. Its BP, EP, and USP grades show it meets some of the tightest standards around for safety and purity.
Plenty of medicines on the pharmacy shelf would not look right, feel right, or work right without this kind of ingredient. I’ve seen tablet blends that clump or break apart in storage if left to their own chemistry. Polyoxyethylene (50) Stearate steps in to prevent problems like those. It makes tablets easier to form and helps powders blend. For liquid drugs, it makes sure the active compounds stay dissolved, so every dose is the same from the first spoonful to the last. If you’ve ever taken a syrup that stayed mixed through its whole bottle, there’s a good chance some kind of stearate or surfactant kept it that way.
One of the key uses involves oral solid dosage forms, such as tablets and capsules. Polyoxyethylene (50) Stearate acts as a lubricant and a wetting agent—important when you want medicine to dissolve predictably in the stomach. During compression, it reduces friction between powder and metal equipment, making manufacturing smoother and cutting down on expensive waste. It also helps powders spread out evenly before compressing, so each tablet feels the same in the hand and delivers a consistent amount of active medicine.
In creams, ointments, and lotions, it steps up as an emulsifier. Oil and water do not like to stick together, which causes lots of headaches when someone tries to get a smooth, stable cream. Polyoxyethylene (50) Stearate binds those molecules together, making a final product that feels pleasant on the skin. The medicines in these mixtures then spread better, and patients are more likely to use them as directed.
Suspensions and syrups, used often for pediatric medicines or for people who can’t swallow pills, also gain from its surfactant action. It keeps active particles from settling to the bottom, ensuring each spoonful provides the benefits intended by the doctor or pharmacist. Solubility and taste maskers make a big difference when getting people—especially kids—to actually take their medicine.
Drugs work best when they’re stable, predictable, and comfortable to take. Patients often never notice what goes into making each pill or liquid just right. Polyoxyethylene (50) Stearate takes care of many technical challenges. Because it’s approved by major pharmacopeias—BP, EP, USP—it’s trusted in regulated medicine. Documentation shows it has low toxicity at recommended levels and gets along well with many drug molecules.
Manufacturers should watch for any new evidence around safety or allergic reactions and continue to search for improvements. Open, clear labeling help doctors and pharmacists guide patients with special sensitivities. Sometimes plant-based alternatives step in, but for many products today, Polyoxyethylene (50) Stearate still does what’s needed.
Polyoxyethylene (50) stearate, a mouthful of a name, crops up a lot in drug formulations. This ingredient helps mix oil and water in medications, which seems simple but makes a big difference. Without it, lots of liquid medicines would separate or look unappealing. Having watched the inside of a small generic tablet plant, I know people working production lines keep a close eye on any chance of clumping or separation. Using the right emulsifier keeps things running smoothly, and this compound has a long track record for that exact job.
Medicines cross country borders, so drug ingredients face global rules. In this case, the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) each set quality standards. Polyoxyethylene (50) stearate must match expectations for purity, absence of hazardous chemicals, and performance—no exceptions. These standards help keep toxic byproducts, like ethylene oxide residues or free fatty acids, out of patients’ systems.
Over the last decade, I’ve come across quality audits where batches failed because someone skipped a step in testing for heavy metals or microbial count. This isn’t just bureaucracy—some contaminants barely visible on paper can trigger real side effects in patients. Complying with the three big pharmacopeias isn’t just routine; it keeps medicines trustworthy and helps avoid large, costly recalls that can erode public confidence.
Safety questions hover over every ingredient, even ones in use for decades. Polyoxyethylene (50) stearate has been around the pharmaceutical block. Major toxicology reports haven’t flagged it for worrying side effects at the doses used in medicine. The digestive system breaks down this compound into parts the body can handle—there’s no bioaccumulation.
On the production floor, even a tiny non-conformity can lead to headaches. Don’t forget patient allergies and sensitivities, either. Regulatory reviews flag allergic reactions based on actual patient complaints, not theoretical risks. Out of personal experience, most troubles arise when mislabeling hides additives rather than from the substance itself.
Not every supplier gets the process right each time. Raw material quality drifts. When suppliers cut corners, contamination creeps in, making quality control crucial. A seasoned pharmacist friend once told me that the safest drug can become harmful if the excipients aren’t pure or the environment’s not tightly controlled.
Regular testing using pharmacopeial methods—think spectroscopy, chromatography, residue analysis—can spot contamination threats early. Technology now lets plants automate some of these checks, but human oversight remains key. For companies, transparent supplier partnerships, routine audits, and investing in better-quality analytics stop surprises before they hit patients.
Pharmaceutical companies balance a long list of must-haves—stability, taste, shelf life, ease of manufacturing—with costs. Polyoxyethylene (50) stearate covers several of these needs robustly and, used properly under pharmacopeial guidance, has a clean bill of health. I’ve watched lab technicians pass batch samples through a battery of tests—color, odor, pH, purity, microbial load—because few risks are worth taking with patient safety. Rules and best practices keep everyone honest and every batch predictable.
Polyoxyethylene (50) stearate remains a reliable tool when everyone in the chain—supplier, manufacturer, regulator—plays by the book. That’s the only way medicines stay safe, effective, and trustworthy year after year.
Polyoxyethylene (50) Stearate stands out in the world of pharmaceuticals as a nonionic surfactant made from stearic acid and polyoxyethylene chains. This chemical structure gives it a distinct set of physical and chemical properties that bring value to manufacturers working to meet BP, EP, and USP benchmarks. Each molecule carries about 50 ethylene oxide units attached to a single stearic acid core. The result is a white to off-white waxy solid or powder that dissolves in water and alcohol. The HLB (hydrophilic-lipophilic balance) value typically falls between 15 and 18, making it a highly hydrophilic surfactant that blends smoothly with both water and oil-based substances. These features help streamline large-scale manufacturing and quality assurance.
Quality doesn't leave room for compromise in the pharma industry. Polyoxyethylene (50) Stearate made for BP, EP, or USP grade must pass a stringent list of requirements. Purity levels run above 98%. Manufacturers demand clear limits for impurities, with heavy metals capped at 10 parts per million (ppm) or less. Acid value, which signals the free acid content, comes in under 2 mg KOH per gram. Saponification value, which informs on the combined presence of fatty acids and esters, typically ranges from 45 to 55 mg KOH per gram. The pH value of a 1% aqueous solution should rest between 5.0 and 7.0.
Trace water often hides in excipients. For Polyoxyethylene (50) Stearate, moisture content should not exceed 2%. Residual solvents rarely reach above 0.5%. Microbial contamination and endotoxin levels catch a lot of attention too, especially since sterile and parenteral products cannot tolerate biological risks. Most pharma manufacturers run advanced in-house testing, relying on validated HPLC and GC methods backed by years of regulatory scrutiny.
In the early days of compounding, I often reached for excipients that claimed to meet pharmacopeial standards, only to find batches that didn't mix or disperse as promised. Today, the push for documented quality has forced suppliers to up their game. Polyoxyethylene (50) Stearate with confirmed BP, EP, or USP compliance takes away a major source of formulation headaches. Its consistency reduces variability in emulsions and creams, and it keeps tablet coatings reliable day in and day out. For soluble drugs or tough-to-mix actives, this excipient improves dispersibility, which helps patients receive the intended dose every time. Reliable dissolution supports predictable drug absorption and does away with frequent batch failures.
Even with strict quality control, inconsistencies can creep in, especially if raw stearic acid comes from variable vegetable or animal sources. I’ve seen batches go off-spec due to changes in suppliers or a lack of tight documentation. Plus, the global spotlight on residual ethylene oxide, a probable carcinogen, has forced tighter monitoring. Independent audits and a shift toward sustainable sourcing help fill in the gaps. Automated in-line testing brings faster error detection. The best suppliers publish full transparency reports, making it easier to trust each batch that comes down the line.
For small and mid-sized pharmaceutical companies, partnering with suppliers who work openly with regulatory agencies pays off. Training formulation scientists about the functional role of Polyoxyethylene (50) Stearate—beyond simple emulsification—cuts down on unnecessary batch reworks. Open dialogue between labs and suppliers over compliance reports and technical dossiers leads to faster troubleshooting and better end products.
People who rely on medicines trust more than just an active ingredient. Every excipient, including Polyoxyethylene (50) Stearate, influences safety and reliability. A shared commitment to rigorous testing, sourcing integrity, and robust documentation builds medicines that perform as promised and safeguard patient well-being. This isn't about ticking quality boxes on a spreadsheet—it's about making sure every tablet, cream, or solution delivered is worthy of patient trust.
Polyoxyethylene (50) Stearate stands out in pharmaceutical labs and factories for its role as a non-ionic surfactant. It keeps up with strict quality standards, which means storage and handling can’t be taken lightly. I remember walking through a busy pharma warehouse where the difference between a stable shipment and a spoiled batch came down to careful attention to simple details.
Too much moisture invites clumping and degradation. This can impact not just how it mixes but also final product safety and stability. Inside every good facility, you’ll find Polyoxyethylene (50) Stearate in tightly sealed original drums or containers, far from water sources, damp air, and open windows. I’ve seen products left exposed develop a crusty layer, making dissolving it the next time nearly impossible. Silica gel packs in storage rooms or dehumidifiers can be real game-changers, especially in humid climates.
Heat does a number on most ingredients, and this one is no exception. Pharma-grade Polyoxyethylene (50) Stearate stores best at cool, stable temperatures—usually around 20 to 25°C. After several years of tracking shipments across seasons, it became pretty clear why companies use air-conditioned or climate-monitored storage spaces. Fluctuations in temperature, like steamy afternoons or chilly nights, compromise texture and can alter its physical state, sometimes leading to separation or discoloration. Cold storage isn’t about deep freezing but rather about avoiding hot spots or direct sunlight.
Cross-contamination in a warehouse can quietly ruin supplies. Even airtight packaging has limits. Fumes from solvents, cleaning supplies, or volatile ingredients drifting through a shared storeroom risk subtle contamination. It makes sense to keep Polyoxyethylene (50) Stearate far from any strong-smelling substances and ensure ventilation runs well. I learned fast to keep it on its own shelf, never next to anything with a strong odor or heavy vapor trail. Staff who handle multiple chemicals should always switch gloves and gear between tasks for the same reason.
Labels fade, containers get shuffled, and confusion sets in, especially during busy production periods. I’ve witnessed mix-ups that wasted entire shipments. Clear, legible labels listing batch numbers, manufacturing dates, and expiry dates can avoid this headache. Standard practice rotates stock, so the oldest batch goes out first—no buried drums lurking in a corner waiting to surprise you with spoiled content. Every team member should know not just where the ingredient goes, but how long it’s been there.
Even substances with low hazard profiles deserve attention to personal safety. Polyoxyethylene (50) Stearate can cause irritation after direct skin or eye contact. Wearing gloves, goggles, and standard lab coats saves a lot of trouble. Spills happen—having neutral absorbent material and a disposal plan makes a difference, especially on busy days. Proper training means everybody knows how to deal with accidents and no one takes shortcuts.
The strongest pharmaceutical companies invest in training and strict protocols. Quality starts at the loading dock, where damaged containers get checked before unpacking. Documentation tracks every lot from receipt to final use, making recalls and investigations much less complicated if something ever does go wrong. Automation helps, but human attention to detail keeps every batch safe and effective. Internal audits and regular reviews refine these practices even more.
Pharma workers deserve well-ventilated, organized spaces, reliable tools, and clear guidelines. Investing in those details means Polyoxyethylene (50) Stearate does its job in the formulation without drama. Pharmacies and manufacturers who focus on proactive storage and careful handling never worry about last-minute surprises and keep products dependable every time they go to market.
Pharmaceutical labs and manufacturers run on precision. Sourcing Polyoxyethylene (50) Stearate under BP, EP, or USP pharma grade standards brings its own set of practical questions. Packaging size ranks high on any purchasing checklist. There’s no universal “one-size-fits-all” here, and that’s probably for the best. Small-scale compounders, quality control divisions, and big batch producers all juggle different amounts based on the scale of their operation.
From my own time consulting smaller research labs, I know the struggle of dealing with chemicals shipped in huge drums when you barely use a kilogram a year. On the other hand, contract manufacturers thrive when suppliers can send 25 kg or 50 kg drums, ensuring less frequent reordering and fewer disruptions. A few calls to chemical distributors show that many offer packs ranging from as little as 1 kg all the way to 200 kg fiber drums, depending on the customer's needs. These options help avoid wastage and cut down on unnecessary costs.
Besides cutting down on logistical headaches, proper packaging keeps the product from picking up impurities. Polyoxyethylene (50) Stearate—being an emulsifier and surfactant—can break down if exposed to moisture, high temperatures, or sunlight. Those who’ve worked in resource-stretched regional hospitals or clinics have stories about half-used, poorly-sealed containers caking up over time, turning a stable ingredient into something you wouldn’t trust in any formulation. Leak-proof sealed packaging and well-thought-out pack sizes really matter beyond just convenience.
Raw materials in pharma don’t last forever, even if the containers look sturdy. Direct from the manufacturer, Polyoxyethylene (50) Stearate comes stamped with a shelf life—sometimes marked “36 months,” as standard for many excipients, but always check the manufacturer’s certificate of analysis. The shelf life often depends on keeping it cool, dry, and shielded from light. I’ve watched powders and emulsifiers degrade faster in storerooms with poor air conditioning, so proper storage isn’t just academic advice.
This has real-world impact. Relying on expired or compromised material can cause a cascade of problems in a finished drug product. A simple slip—a tiny breach in packaging, storage at hotter-than-recommended temperatures, or opening a drum far ahead of schedule—can erode the very quality standards regulators like the FDA and EMA expect. That’s not just a paperwork headache; it’s a risk to patient safety and your company’s reputation. Documentation that includes batch numbers, expiry dates, and handling advice is a must—no excuses.
Lowering costs shouldn’t mean cutting safety corners. Buying the smallest amount needed, verifying the supplier’s packaging, and having clear rotation systems in storage all play a role in keeping ingredients within shelf life. Firms introducing more digital inventory management can spot stock close to expiring before it even hits a production line. Some contract manufacturers jointly plan orders with suppliers to match production schedules so stocks move before shelf life issues arise. That approach didn’t just save dollars; it also reduced the scrambling panic when a half-used container went out of spec.
Open lines with chemical suppliers clarify what’s available in the right pack sizes and how fresh those lots are. In my work brokering pharma-grade excipient deals, the labs that checked in regularly with their vendors dodged lots of drama: no mystery batches sitting too long on a warehouse shelf, no guessing about packaging conditions. It pays to ask—and double-check—the shelf life and packaging before every order.
Names | |
Preferred IUPAC name | Polyoxyethylene stearate |
Other names |
Myrj 53 PEG-50 Stearate Polyethylene Glycol (50) Stearate POE (50) Stearate Ethoxylated Stearic Acid (50 moles EO) Polyoxyl 50 Stearate |
Pronunciation | /ˌpɒliˌɒksɪˈiːθiˌliːn ˈfɪfti stɪəˈreɪt biː piː iː piː juː ɛs piː ˈfɑːrmə ɡreɪd/ |
Identifiers | |
CAS Number | 9004-99-3 |
Beilstein Reference | 4830862 |
ChEBI | CHEBI:8000 |
ChEMBL | CHEMBL1201474 |
ChemSpider | 54812 |
DrugBank | DB11160 |
ECHA InfoCard | ECHA InfoCard: 01-2119958808-15-XXXX |
EC Number | 500-018-3 |
Gmelin Reference | 28643 |
KEGG | C16118 |
MeSH | Polyoxyethylene Stearates |
PubChem CID | 656849 |
RTECS number | WK4975000 |
UNII | 4R1V969T5B |
UN number | UN3265 |
Properties | |
Chemical formula | C₁₀₀H₂₀₂O₅₁ |
Molar mass | 3549 g/mol |
Appearance | White or yellowish, waxy solid or powder |
Odor | Odorless |
Density | 1.08 g/cm³ |
Solubility in water | Soluble in water |
log P | -0.26 |
Acidity (pKa) | ~4.5 |
Basicity (pKb) | 13.8 |
Refractive index (nD) | 1.453 |
Viscosity | 60-160 cP (25°C) |
Dipole moment | 2.9 D |
Thermochemistry | |
Std molar entropy (S⦵298) | 158 J·mol⁻¹·K⁻¹ |
Pharmacology | |
ATC code | A06AD15 |
Hazards | |
Main hazards | May cause eye, skin, and respiratory irritation. |
GHS labelling | GHS labelling: Not classified as hazardous according to GHS. |
Pictograms | GHS07, GHS08 |
Signal word | Warning |
Hazard statements | No hazard statements. |
Precautionary statements | Precautionary statements: P264, P280, P305+P351+P338, P337+P313, P501 |
NFPA 704 (fire diamond) | 1-1-0 |
Flash point | > 210 °C |
Lethal dose or concentration | LD50 (Rat, oral): > 25,000 mg/kg |
LD50 (median dose) | LD50 (median dose): 32,000 mg/kg (rat, oral) |
NIOSH | TRN9488700 |
PEL (Permissible) | Not established |
REL (Recommended) | Not more than 25 mg/kg body weight |
Related compounds | |
Related compounds |
Polyoxyethylene (20) Stearate Polyoxyethylene (40) Stearate Polyoxyethylene (100) Stearate Polyethylene Glycol Stearate Polysorbate 60 Polysorbate 80 Steareth-10 Steareth-20 |